STARTUP PROFILE

Neuspera

COUNTRY
USA
FOUNDED
2019
CATEGORY
Neuromodulation
Developing a wirelessly powered implantable neuromodulation system for treating pelvic health and chronic neurological conditions.
Visit website →
Neurofounders Insights
$   Funding   -
Series C+
MODALITY
Nerve stimulator
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Other
TARGET USER
Patients
REGULATORY STAGE
FDA approved (PMA)
Neuspera is one of the more commercially advanced wireless implant companies, using a battery-free architecture for neuromodulation in pelvic and chronic conditions. Its PMA-level status puts it ahead of many similarly miniaturized implant startups.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Neuspera
No items found.